| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.29 | 0.1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.1 |